Crossref
KRAS Oncoprotein Signaling in Cancer
New England Journal of Medicine · 16.01.2025 · 392 (3) · 296-298
DOI: 10.1056/nejmcibr2408099 ↗Kurz gefasst
Fachartikel in der Zeitschrift New England Journal of Medicine, erschienen am 16.01.2025. Verfasst von Piro Lito. Beteiligte Einrichtung: From the Human Oncology and Pathogenesis Program and the Department of Medicine, Memorial Sloan Kettering Cancer Center, New York. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- From the Human Oncology and Pathogenesis Program and the Department of Medicine, Memorial Sloan Kettering Cancer Center, New York.
Zitieren
APA
Lito, P. (2025). KRAS Oncoprotein Signaling in Cancer. New England Journal of Medicine, 392(3), 296-298. https://doi.org/10.1056/nejmcibr2408099
Vancouver
Lito P. KRAS Oncoprotein Signaling in Cancer. New England Journal of Medicine. 2025;392(3):296-298. doi:10.1056/nejmcibr2408099
BibTeX
@article{Lito2025,
author = {Lito, Piro},
title = {KRAS Oncoprotein Signaling in Cancer},
journal = {New England Journal of Medicine},
year = {2025},
volume = {392},
number = {3},
pages = {296--298},
doi = {10.1056/nejmcibr2408099}
}
EUVIMED